Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice

Brain, Behavior, and Immunity

Volumn 48, Issue , 2015, Pages 86-101

  Babcock, Alicia A ^a   Ilkjær, Laura ^a   Clausen, Bettina H ^a   Villadsen, Birgitte ^a   Dissing Olesen, Lasse ^a   Bendixen, Anita T M ^a   Lyck, Lise ^a   Lambertsen, Kate L ^a   Finsen, Bente ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Alzheimer's disease; Flow cytometry; IL 1; IL 1Ra; In vivo; Microglia; Neuroinflammation; Phagocytosis; Stereology; TNF

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; CD11B ANTIGEN; CD45 ANTIGEN; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; MESSENGER RNA; TUMOR NECROSIS FACTOR; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CYTOKINE; PRESENILIN 1;

AGE; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL TISSUE; ARTICLE; BONE MARROW; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GENE EXPRESSION; ILLNESS TRAJECTORY; MICROGLIA; MOUSE; MOUSE MODEL; NEOCORTEX; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; TRANSGENIC MOUSE; WILD TYPE MOUSE; ANIMAL; BRAIN; DISEASE MODEL; GENETICS; METABOLISM;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; CYTOKINES; DISEASE MODELS, ANIMAL; MICE; MICE, TRANSGENIC; MICROGLIA; PRESENILIN-1;

EID: 84929273267     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2015.03.006     Document Type: Article

References (104)

1. Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G.M., Cooper, N.R., Eikelenboom, P., Emmerling, M., Fiebich, B.L., Finch, C.E., Frautschy, S., Griffin, W.S., Hampel, H., Hull, M., Landreth, G., Lue, L., Mrak, R., Mackenzie, I.R., McGeer, P.L., O'Banion, M.K., Pachter, J., Pasinetti, G., Plata-Salaman, C., Rogers, J., Rydel, R., Shen, Y., Streit, W., Strohmeyer, R., Tooyoma, I., Van Muiswinkel, F.L., Veerhuis, R., Walker, D., Webster, S., Wegrzyniak, B., Wenk, G., Wyss-Coray, T., 2000. Inflammation and Alzheimer's disease. Neurobiol. Aging 21, 383-421.
2. Babcock, A.A., Kuziel, W.A., Rivest, S., Owens, T., 2003. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J. Neurosci. 23, 7922-7930.
3. Babcock, A.A., Toft-Hansen, H., Owens, T., 2008. Signaling through MyD88 regulates leukocyte recruitment after brain injury. J. Immunol. 181, 6481-6490.
4. Babcock, A.A., Wirenfeldt, M., Finsen, B., 2013. Quantification of microglial proliferation and apoptosis by flow cytometry. Methods Mol. Biol. 1041, 129-145.
5. Babcock, A.A., Wirenfeldt, M., Holm, T., Nielsen, H.H., Dissing-Olesen, L., Toft-Hansen, H., Millward, J.M., Landmann, R., Rivest, S., Finsen, B., Owens, T., 2006. Toll-like receptor 2 signaling in response to brain injury: an innate bridge to neuroinflammation. J. Neurosci. 26, 12826-12837.
6. Baron, R., Babcock, A.A., Nemirovsky, A., Finsen, B., Monsonego, A., 2014. Accelerated microglial pathology is associated with Abeta plaques in mouse models of Alzheimer's disease. Aging Cell 13, 584-595.
7. Blum-Degen, D., Muller, T., Kuhn, W., Gerlach, M., Przuntek, H., Riederer, P., 1995. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci. Lett. 202, 17-20.
8. Boissonneault, V., Filali, M., Lessard, M., Relton, J., Wong, G., Rivest, S., 2009. Powerful beneficial effects of macrophage colony-stimulating factor on betaamyloid deposition and cognitive impairment in Alzheimer's disease. Brain 132, 1078-1092.
9. Bolmont, T., Haiss, F., Eicke, D., Radde, R., Mathis, C.A., Klunk, W.E., Kohsaka, S., Jucker, M., Calhoun, M.E., 2008. Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance. J. Neurosci. 28, 4283-4292.
10. Butovsky, O., Siddiqui, S., Gabriely, G., Lanser, A.J., Dake, B., Murugaiyan, G., Doykan, C.E., Wu, P.M., Gali, R.R., Iyer, L.K., Lawson, R., Berry, J., Krichevsky, A.M., Cudkowicz, M.E., Weiner, H.L., 2012. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J. Clin. Investig. 122, 3063-3087.
11. Cacabelos, R., Alvarez, X.A., Fernandez-Novoa, L., Franco, A., Mangues, R., Pellicer, A., Nishimura, T., 1994. Brain interleukin-1 beta in Alzheimer's disease and vascular dementia. Methods Find. Exp. Clin. Pharmacol. 16, 141-151.
12. Cacabelos, R., Barquero, M., Garcia, P., Alvarez, X.A., Varela de Seijas, E., 1991. Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disorders. Methods Find. Exp. Clin. Pharmacol. 13, 455-458.
13. Cagnin, A., Brooks, D.J., Kennedy, A.M., Gunn, R.N., Myers, R., Turkheimer, F.E., Jones, T., Banati, R.B., 2001. In-vivo measurement of activated microglia in dementia. Lancet 358, 461-467.
14. Cheng, X., Shen, Y., Li, R., 2014. Targeting TNF: a therapeutic strategy for Alzheimer's disease. Drug Discov Today.
15. Clausen, B., Fenger, C., Finsen, B., 2013. In situ hybridization of cytokine mRNA using alkaline phosphatase-labelled oligodeoxynucleotide probes. Methods Mol. Biol. 1041, 83-91.
16. Clausen, B.H., Lambertsen, K.L., Babcock, A.A., Holm, T.H., Dagnaes-Hansen, F., Finsen, B., 2008. Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J. Neuroinflam. 5, 46.
17. Colton, C., Wilcock, D.M., 2010. Assessing activation states in microglia. CNS Neurol. Disord.: Drug Targets 9, 174-191.
18. Delay, C., Mandemakers, W., Hebert, S.S., 2012. MicroRNAs in Alzheimer's disease. Neurobiol. Dis. 46, 285-290.
19. Dickson, D.W., Lee, S.C., Mattiace, L.A., Yen, S.H., Brosnan, C., 1993. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7, 75-83.
20. Dilger, R.N., Johnson, R.W., 2008. Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system. J. Leukoc. Biol. 84, 932-939.
21. Eikelenboom, P., Veerhuis, R., Scheper, W., Rozemuller, A.J., van Gool, W.A., Hoozemans, J.J., 2006. The significance of neuroinflammation in understanding Alzheimer's disease. J. Neural Transm. 113, 1685-1695.
22. El Khoury, J., Toft, M., Hickman, S.E., Means, T.K., Terada, K., Geula, C., Luster, A.D., 2007. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 13, 432-438.
23. Fenger, C., Drojdahl, N., Wirenfeldt, M., Sylvest, L., Jorgensen, O.S., Meldgaard, M., Lambertsen, K.L., Finsen, B., 2006. Tumor necrosis factor and its p55 and p75 receptors are not required for axonal lesion-induced microgliosis in mouse fascia dentata. Glia 54, 591-605.
24. Floden, A.M., Combs, C.K., 2011. Microglia demonstrate age-dependent interaction with amyloid-beta fibrils. J. Alzheimers Dis. 25, 279-293.
25. Frank, M.G., Barrientos, R.M., Biedenkapp, J.C., Rudy, J.W., Watkins, L.R., Maier, S.F., 2006. MRNA up-regulation of MHC II and pivotal pro-inflammatory genes in normal brain aging. Neurobiol. Aging 27, 717-722.
26. Gaglani, S.M., Lu, L., Williams, R.W., Rosen, G.D., 2009. The genetic control of neocortex volume and covariation with neocortical gene expression in mice. BMC Neurosci. 10, 44.
27. Gandy, S., 2014. Alzheimer's disease: new data highlight nonneuronal cell types and the necessity for presymptomatic prevention strategies. Biol. Psychiatry 75, 553-557.
28. Garcia-Alloza, M., Robbins, E.M., Zhang-Nunes, S.X., Purcell, S.M., Betensky, R.A., Raju, S., Prada, C., Greenberg, S.M., Bacskai, B.J., Frosch, M.P., 2006. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol. Dis. 24, 516-524.
29. Garlanda, C., Dinarello, C.A., Mantovani, A., 2013. The interleukin-1 family: back to the future. Immunity 39, 1003-1018.
30. Godbout, J.P., Chen, J., Abraham, J., Richwine, A.F., Berg, B.M., Kelley, K.W., Johnson, R.W., 2005. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J. 19, 1329-1331.
31. Griffin, W.S., Stanley, L.C., Ling, C., White, L., MacLeod, V., Perrot, L.J., White 3rd, C.L., Araoz, C., 1989. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 86, 7611-7615.
32. Guillot-Sestier, M.V., Town, T., 2013. Innate immunity in Alzheimer's disease: a complex affair. CNS Neurol. Disord.: Drug Targets 12, 593-607.
33. Halle, A., Hornung, V., Petzold, G.C., Stewart, C.R., Monks, B.G., Reinheckel, T., Fitzgerald, K.A., Latz, E., Moore, K.J., Golenbock, D.T., 2008. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 9, 857-865.
34. Hanisch, U.K., 2013. Functional diversity of microglia - how heterogeneous are they to begin with? Front. Cell Neurosci. 7, 65.
35. He, P., Zhong, Z., Lindholm, K., Berning, L., Lee, W., Lemere, C., Staufenbiel, M., Li, R., Shen, Y., 2007. Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice. J. Cell Biol. 178, 829-841.
36. Hefendehl, J.K., Neher, J.J., Suhs, R.B., Kohsaka, S., Skodras, A., Jucker, M., 2014. Homeostatic and injury-induced microglia behavior in the aging brain. Aging Cell 13, 60-69.
37. Heneka, M.T., Kummer, M.P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., Gelpi, E., Halle, A., Korte, M., Latz, E., Golenbock, 2012. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 493, 674-678.
38. Heneka, M.T., Sastre, M., Dumitrescu-Ozimek, L., Dewachter, I., Walter, J., Klockgether, T., Van Leuven, F., 2005. Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice. J. Neuroinflam. 2, 22.
39. Hickman, S.E., Allison, E.K., El Khoury, J., 2008. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J. Neurosci. 28, 8354-8360.
40. Hickman, S.E., Kingery, N.D., Ohsumi, T.K., Borowsky, M.L., Wang, L.-C., Means, T.K., El Khoury, J., 2013. The microglial sensome revealed by direct RNA sequencing. Nat. Neurosci. 16, 1896-1905.
41. Hjorth, E., Frenkel, D., Weiner, H., Schultzberg, M., 2010. Effects of immunomodulatory substances on phagocytosis of abeta(1-42) by human microglia. Int. J. Alzheimers Dis., 2010
42. Hofman, F.M., Hinton, D.R., Johnson, K., Merrill, J.E., 1989. Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170, 607-612.
43. Hyman, B.T., Phelps, C.H., Beach, T.G., Bigio, E.H., Cairns, N.J., Carrillo, M.C., Dickson, D.W., Duyckaerts, C., Frosch, M.P., Masliah, E., Mirra, S.S., Nelson, P.T., Schneider, J.A., Thal, D.R., Thies, B., Trojanowski, J.Q., Vinters, H.V., Montine, T.J., 2012. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement. 8, 1-13.
44. Jack Jr., C.R., Knopman, D.S., Jagust, W.J., Shaw, L.M., Aisen, P.S., Weiner, M.W., Petersen, R.C., Trojanowski, J.Q., 2010. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9, 119-128.
45. Jack Jr., C.R., Wiste, H.J., Lesnick, T.G., Weigand, S.D., Knopman, D.S., Vemuri, P., Pankratz, V.S., Senjem, M.L., Gunter, J.L., Mielke, M.M., Lowe, V.J., Boeve, B.F., Petersen, R.C., 2013. Brain beta-amyloid load approaches a plateau. Neurology 80, 890-896.
46. Janelsins, M.C., Mastrangelo, M.A., Park, K.M., Sudol, K.L., Narrow, W.C., Oddo, S., LaFerla, F.M., Callahan, L.M., Federoff, H.J., Bowers, W.J., 2008. Chronic neuronspecific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3 × Tg-AD mice. Am. J. Pathol. 173, 1768-1782.
47. Jankowsky, J.L., Fadale, D.J., Anderson, J., Xu, G.M., Gonzales, V., Jenkins, N.A., Copeland, N.G., Lee, M.K., Younkin, L.H., Wagner, S.L., Younkin, S.G., Borchelt, D.R., 2004. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet. 13, 159-170.
48. Jimenez, S., Baglietto-Vargas, D., Caballero, C., Moreno-Gonzalez, I., Torres, M., Sanchez-Varo, R., Ruano, D., Vizuete, M., Gutierrez, A., Vitorica, J., 2008. Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer's disease: age-dependent switch in the microglial phenotype from alternative to classic. J. Neurosci. 28, 11650-11661.
49. Khan, A.M., Babcock, A.A., Saeed, H., Myhre, C.L., Kassem, M., Finsen, B., 2015. Telomere dysfunction reduces microglial numbers without fully inducing an aging phenotype. Neurobiol. Aging. http://dx.doi.org/10.1016/j.neurobiolaging.2015.03.008.
50. Koenigsknecht-Talboo, J., Landreth, G.E., 2005. Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines. J. Neurosci. 25, 8240-8249.
51. Krabbe, G., Halle, A., Matyash, V., Rinnenthal, J.L., Eom, G.D., Bernhardt, U., Miller, K.R., Prokop, S., Kettenmann, H., Heppner, F.L., 2013. Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS One 8, e60921.
52. Lai, A.Y., McLaurin, J., 2012. Clearance of amyloid-b peptides by microglia and macrophages: the issue of what, when and where. Future Neurol. 7, 165-176.
53. Lambertsen, K.L., Biber, K., Finsen, B., 2012. Inflammatory cytokines in experimental and human stroke. J. Cereb. Blood Flow Metab.
54. Lambertsen, K.L., Clausen, B.H., Babcock, A.A., Gregersen, R., Fenger, C., Nielsen, H.H., Haugaard, L.S., Wirenfeldt, M., Nielsen, M., Dagnaes-Hansen, F., Bluethmann, H., Faergeman, N.J., Meldgaard, M., Deierborg, T., Finsen, B., 2009. Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J. Neurosci. 29, 1319-1330.
55. Lanzrein, A.S., Johnston, C.M., Perry, V.H., Jobst, K.A., King, E.M., Smith, A.D., 1998. Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin. Alzheimer Dis. Assoc. Disord. 12, 215-227.
56. Lee, C.Y.D., Landreth, G.E., 2010. The role of microglia in amyloid clearance from the AD brain. J. Neural Transm. 117, 949-960.
57. Lee, S., Varvel, N.H., Konerth, M.E., Xu, G., Cardona, A.E., Ransohoff, R.M., Lamb, B.T., 2010. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. Am. J. Pathol. 177, 2549-2562.
58. Liu, Y., Yoo, M.J., Savonenko, A., Stirling, W., Price, D.L., Borchelt, D.R., Mamounas, L., Lyons, W.E., Blue, M.E., Lee, M.K., 2008. Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer's disease. J. Neurosci. 28, 13805-13814.
59. Liu, Z., Condello, C., Schain, A., Harb, R., Grutzendler, J., 2010. CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-beta phagocytosis. J. Neurosci. 30, 17091-17101.
60. Lyck, L., Kroigard, T., Finsen, B., 2007. Unbiased cell quantification reveals a continued increase in the number of neocortical neurones during early postnatal development in mice. Eur. J. Neurosci. 26, 1749-1764.
61. Lynch, A.M., Murphy, K.J., Deighan, B.F., O'Reilly, J.A., Gun'ko, Y.K., Cowley, T.R., Gonzalez-Reyes, R.E., Lynch, M.A., 2010. The impact of glial activation in the aging brain. Aging and disease 1, 262-278.
62. Mahad, D., Callahan, M.K., Williams, K.A., Ubogu, E.E., Kivisakk, P., Tucky, B., Kidd, G., Kingsbury, G.A., Chang, A., Fox, R.J., Mack, M., Sniderman, M.B., Ravid, R., Staugaitis, S.M., Stins, M.F., Ransohoff, R.M., 2006. Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis. Brain 129, 212-223.
63. Mandrekar, S., Jiang, Q., Lee, C.Y.D., Koenigsknecht-Talboo, J., Holtzman, D.M., Landreth, G.E., 2009. Microglia mediate the clearance of soluble a through fluid phase macropinocytosis. J. Neurosci. 29, 4252-4262.
64. Mawuenyega, K.G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J.C., Yarasheski, K.E., Bateman, R.J., 2010. Decreased clearance of CNS - amyloid in Alzheimer's disease. Science 330, 1774.
65. McAlpine, F.E., Lee, J.K., Harms, A.S., Ruhn, K.A., Blurton-Jones, M., Hong, J., Das, P., Golde, T.E., LaFerla, F.M., Oddo, S., Blesch, A., Tansey, M.G., 2009. Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents preplaque amyloid-associated neuropathology. Neurobiol. Dis. 34, 163-177.
66. Mildner, A., Schmidt, H., Nitsche, M., Merkler, D., Hanisch, U.-K., Mack, M., Heikenwalder, M., Brück, W., Priller, J., Prinz, M., 2007. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat. Neurosci. 10, 1544-1553.
67. Nelson, P.T., Alafuzoff, I., Bigio, E.H., Bouras, C., Braak, H., Cairns, N.J., Castellani, R.J., Crain, B.J., Davies, P., Tredici, K.D., Duyckaerts, C., Frosch, M.P., Haroutunian, V., Hof, P.R., Hulette, C.M., Hyman, B.T., Iwatsubo, T., Jellinger, K.A., Jicha, G.A., Kövari, E., Kukull, W.A., Leverenz, J.B., Love, S., Mackenzie, I.R., Mann, D.M., Masliah, E., McKee, A.C., Montine, T.J., Morris, J.C., Schneider, J.A., Sonnen, J.A., Thal, D.R., Trojanowski, J.Q., Troncoso, J.C., Wisniewski, T., Woltjer, R.L., Beach, T.G., 2012. Correlation of Alzheimer disease neuropathologic changes with cognitive status. J. Neuropathol. Exp. Neurol. 71, 362-381.
68. Nikolajsen, G.N., Jensen, M.S., West, M.J., 2011. Cholinergic axon length reduced by 300 meters in the brain of an Alzheimer mouse model. Neurobiol. Aging 32, 1927-1931.
69. Njie, E.G., Boelen, E., Stassen, F.R., Steinbusch, H.W., Borchelt, D.R., Streit, W.J., 2012. Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function. Neurobiol. Aging 33 (195), e191-112.
70. Oh, E.S., Savonenko, A.V., King, J.F., Fangmark Tucker, S.M., Rudow, G.L., Xu, G., Borchelt, D.R., Troncoso, J.C., 2009. Amyloid precursor protein increases cortical neuron size in transgenic mice. Neurobiol. Aging 30, 1238-1244.
71. Perry, V.H., Cunningham, C., Holmes, C., 2007. Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol. 7, 161-167.
72. Regeur, L., Jensen, G.B., Pakkenberg, H., Evans, S.M., Pakkenberg, B., 1994. No global neocortical nerve cell loss in brains from patients with senile dementia of Alzheimer's type. Neurobiol. Aging 15, 347-352.
73. Remington, L.T., Babcock, A.A., Zehntner, S.P., Owens, T., 2007. Microglial recruitment, activation, and proliferation in response to primary demyelination. Am. J. Pathol. 170, 1713-1724.
74. Ruan, L., Kang, Z., Pei, G., Le, Y., 2009. Amyloid deposition and inflammation in APPswe/PS1dE9 mouse model of Alzheimer's disease. Curr. Alzheimer Res. 6, 531-540.
75. Schaefer, B.C., Schaefer, M.L., Kappler, J.W., Marrack, P., Kedl, R.M., 2001. Observation of antigen-dependent CD8+ T-cell/dendritic cell interactions in vivo. Cell. Immunol. 214, 110-122.
76. Sedgwick, J.D., Schwender, S., Imrich, H., Dorries, R., Butcher, G.W., ter Meulen, V., 1991. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc. Natl. Acad. Sci. U.S.A. 88, 7438-7442.
77. Selmaj, K., Raine, C.S., Cannella, B., Brosnan, C.F., 1991. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87, 949-954.
78. Serrano-Pozo, A., Mielke, M.L., Gomez-Isla, T., Betensky, R.A., Growdon, J.H., Frosch, M.P., Hyman, B.T., 2011. Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's disease. The American journal of pathology 179, 1373-1384.
79. Shaftel, S.S., Griffin, W.S., O'Banion, M.K., 2008. The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J. Neuroinflam. 5, 7.
80. Sheng, J.G., Mrak, R.E., Griffin, W.S., 1995. Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution. Neuropathol. Appl. Neurobiol. 21, 290-301.
81. Sheng, J.G., Mrak, R.E., Griffin, W.S., 1997. Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms. Acta Neuropathol. 94, 1-5.
82. Shi, J.Q., Shen, W., Chen, J., Wang, B.R., Zhong, L.L., Zhu, Y.W., Zhu, H.Q., Zhang, Q.Q., Zhang, Y.D., Xu, J., 2011. Anti-TNF-alpha reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains. Brain Res. 1368, 239-247.
83. Sierra, A., Gottfried-Blackmore, A.C., McEwen, B.S., Bulloch, K., 2007. Microglia derived from aging mice exhibit an altered inflammatory profile. Glia 55, 412-424.
84. Simard, A.R., Soulet, D., Gowing, G., Julien, J.-P., Rivest, S., 2006. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49, 489-502.
85. Steinkamp, J.A., Wilson, J.S., Saunders, G.C., Stewart, C.C., 1982. Phagocytosis: flow cytometric quantitation with fluorescent microspheres. Science 215, 64-66.
86. Streit, W.J., Braak, H., Xue, Q.-S., Bechmann, I., 2009. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol. 118, 475-485.
87. Tang, Y., Le, W., 2015. Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases. Mol. Neurobiol.
88. Tarkowski, E., Andreasen, N., Tarkowski, A., Blennow, K., 2003. Intrathecal inflammation precedes development of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 74, 1200-1205.
89. Tarkowski, E., Blennow, K., Wallin, A., Tarkowski, A., 1999. Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J. Clin. Immunol. 19, 223-230.
90. Tarkowski, E., Liljeroth, A.M., Nilsson, A., Minthon, L., Blennow, K., 2001. Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 12, 314-317.
91. Thal, D.R., Griffin, W.S., Braak, H., 2008. Parenchymal and vascular Abeta-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease. J. Cell Mol. Med. 12, 1848-1862.
92. Townsend, K.P., Town, T., Mori, T., Lue, L.F., Shytle, D., Sanberg, P.R., Morgan, D., Fernandez, F., Flavell, R.A., Tan, J., 2005. CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide. Eur. J. Immunol. 35, 901-910.
93. Vom Berg, J., Prokop, S., Miller, K.R., Obst, J., Kalin, R.E., Lopategui-Cabezas, I., Wegner, A., Mair, F., Schipke, C.G., Peters, O., Winter, Y., Becher, B., Heppner, F.L., 2012. Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline. Nat. Med. 18, 1812-1819.
94. Wang, L.L., Huang, Y., Wang, G., Chen, S.D., 2012. The potential role of microRNA-146 in Alzheimer's disease: biomarker or therapeutic target? Med. Hypotheses 78, 398-401.
95. West, M.J., Bach, G., Soderman, A., Jensen, J.L., 2009. Synaptic contact number and size in stratum radiatum CA1 of APP/PS1DeltaE9 transgenic mice. Neurobiol. Aging 30, 1756-1776.
96. West, M.J., Ostergaard, K., Andreassen, O.A., Finsen, B., 1996. Estimation of the number of somatostatin neurons in the striatum: an in situ hybridization study using the optical fractionator method. J. Comp. Neurol. 370, 11-22.
97. Wilberding, A., Morimoto, K., Satoh, H., Harano, K., Harano, T., Arita, S., Tooyama, I., Konishi, Y., 2008. Multiple cytokines are involved in the early events leading to the Alzheimer's disease pathology. Tottori Rinsho Kagaku Kenkyukai Shi 1, 359-373.
98. Wirenfeldt, M., Babcock, A.A., Ladeby, R., Lambertsen, K.L., Dagnaes-Hansen, F., Leslie, R.G., Owens, T., Finsen, B., 2005. Reactive microgliosis engages distinct responses by microglial subpopulations after minor central nervous system injury. J. Neurosci. Res. 82, 507-514.
99. Wirenfeldt, M., Babcock, A.A., Vinters, H.V., 2011. Microglia - insights into immune system structure, function, and reactivity in the central nervous system. Histol. Histopathol. 26, 519-530.
100. Wirenfeldt, M., Dissing-Olesen, L., Babcock, A.A., Nielsen, M., Meldgaard, M., Zimmer, J., Azcoitia, I., Leslie, R.G., Dagnaes-Hansen, F., Finsen, B., 2007. Population control of resident and immigrant microglia by mitosis and apoptosis. Am. J. Pathol. 171, 617-631.
101. Wood, J.A., Wood, P.L., Ryan, R., Graff-Radford, N.R., Pilapil, C., Robitaille, Y., Quirion, R., 1993. Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein. Brain Res. 629, 245-252.
102. World Health Organization and Alzheimer's Disease International, 2012. Dementia: A Public Health Priority. WHO Press, Geneva, Switzerland.
103. Yasuhara, O., Matsuo, A., Terai, K., Walker, D.G., Berger, A.E., Akiguchi, I., Kimura, J., McGeer, P.L., 1997. Expression of interleukin-1 receptor antagonist protein in post-mortem human brain tissues of Alzheimer's disease and control cases. Acta Neuropathol. 93, 414-420.
104. Zahs, K.R., Ashe, K.H., 2010. 'Too much good news' - are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease? Trends Neurosci. 33, 381-389.